A randomized, placebo-controlled, double-blinded pilot study of angiotensin 1–7 (TXA-127) for the treatment of severe COVID-19

Detalles Bibliográficos
Autores principales: Wagener, Gebhard, Goldklang, Monica P., Gerber, Adam, Elisman, Katerina, Eiseman, Katherine A., Fonseca, Laura D., D’Armiento, Jeanine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332096/
https://www.ncbi.nlm.nih.gov/pubmed/35902867
http://dx.doi.org/10.1186/s13054-022-04096-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9332096/
https://www.ncbi.nlm.nih.gov/pubmed/35902867
http://dx.doi.org/10.1186/s13054-022-04096-9

Ejemplares similares